Detalles de la búsqueda
1.
Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses.
Infect Dis Ther
; 13(4): 875-889, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38570444
2.
Two-Drug Regimens Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine Are Effective with Few Discontinuations in US Real-World Settings: Results from the TANDEM Study.
Infect Dis Ther
; 13(4): 891-906, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38570443
3.
Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I: A Systematic Literature Review and Meta-analysis.
Open Forum Infect Dis
; 10(11): ofad526, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-38033982
4.
Changes in Inflammatory and Atherogenesis Biomarkers With the 2-Drug Regimen Dolutegravir Plus Lamivudine in Antiretroviral Therapy-Experienced, Virologically Suppressed People With HIV-1: A Systematic Literature Review.
Open Forum Infect Dis
; 9(4): ofac068, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35265729
5.
Illness, death, and macronutrients: adequacy of rural Mozambican household production of macronutrients in the face of HIV/AIDS.
Food Nutr Bull
; 28(2 Suppl): S331-8, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17658079
6.
Real-World Effectiveness of Simeprevir-containing Regimens Among Patients With Chronic Hepatitis C Virus: The SONET Study.
Open Forum Infect Dis
; 4(1): ofw258, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28480251
Resultados
1 -
6
de 6
1
Próxima >
>>